Browse by region

World Map Middle East Africa South Asia Asia/Pacific Europe South America North America

Yellow fever vaccination booster not needed

(WHO) The yellow fever ‘booster’ vaccination given ten years after the initial vaccination is not necessary, according to WHO. An article published in WHO’s Weekly Epidemiological Record (WER) reveals that the Organization’s Strategic Advisory Group of Experts on immunization (SAGE) has reviewed the latest evidence and concluded that a single dose  Read More »

Legal status of GMO probe team queried

(Daily Nation: Kenya) The legality of a taskforce investigating the safety of genetically modified crops has been cast into doubt. Concerns have arisen that its members were not legally constituted as they have not been gazetted, in line with government requirements. As a result, Kenyans might not have a chance to  Read More »

Development underway for first transgenic sugarcane plantation

(The Jakarta Post) The National Genetically Modified Product Biosafety Commission (KKHPRG) recently approved the first genetically-altered sugarcane crop, paving the way for the development of transgenic sugarcane for commercial production. Bambang Purwantara, a member of the commission, said that the institutions which held the mandate to approve biotech plants had all  Read More »

Test IDs All Foot-and-Mouth Virus Serotypes

(Laboratory Equipment) U.S. Department of Agriculture (USDA) scientists have developed a new cell line that rapidly and accurately detects foot-and-mouth disease virus (FMDV), which causes a highly contagious and economically devastating disease in cattle and other cloven-hoofed animals.The cell line was created by Agricultural Research Service (ARS) scientists at the Plum  Read More »

Singapore’s First Home-Grown Influenza Vaccine In Phase 1 Clinical Trial

(Medical News Today) Singapore’s Agency for Science, Technology and Research (A*STAR) and Switzerland’s Cytos Biotechnology AG today announced that the first healthy volunteer has been dosed in a Phase 1 clinical trial with their H1N1 influenza vaccine candidate based on Cytos’ proprietary bacteriophage Qbeta virus-like particle (VLP) technology.